1-9 of 9
Rebecca Garris, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frontline Ofatumumab in Combination with Hyper-CVAD for Adult Patients with CD-20 Positive Acute Lymphoblastic Leukemia (ALL): Interim Result of a Phase II Clinical Trial

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Naval Daver, MD, Tapan M. Kadia, MD, Rita B. Khouri, Yesid Alvarado, MD, Jan A. Burger, MD PhD, Deborah A Thomas, MD, Guillermo Garcia-Manero, MD, Courtney D DiNardo, MD, Naveen Pemmaraju, MD, Nicholas J. Short, MD, Heather Schroeder, RN, Rebecca Garris, MS, Prithviraj Bose, MD, Nitin Jain, MD, Kiran Naqvi, MD, William G. Wierda, MD PhD, Srdan Verstovsek, MD PhD, Jorge E. Cortes, MD, Marina Konopleva, MD PhD, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2016) 128 (22): 2783.
https://doi.org/10.1182/blood.V128.22.2783.2783
Published: 2016
Journal Articles

Achievement of Minimal Residual Disease Negativity By Multiparameter Flow Cytometry Is an Important Therapeutic Endpoint in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Receiving Salvage Treatment

Nicholas J. Short, MD, Hagop M. Kantarjian, MD, Jeffrey L. Jorgensen, MD PhD, Farhad Ravandi, MD, Musa Yilmaz, MD, Maria R. Khouri, Sa Wang, MD, Deborah A Thomas, MD, Joseph D Khoury, MD, Richard E. Champlin, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, David Marin, MD, Susan M. O'Brien, MD, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Koji Sasaki, MD, Courtney D DiNardo, MD, Tapan M. Kadia, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Rebecca Garris, MS, Elias J. Jabbour, MD
Journal: Blood
Blood (2016) 128 (22): 2916.
https://doi.org/10.1182/blood.V128.22.2916.2916
Published: 2016
Journal Articles

Phase II Study of the Frontline Hyper-CVAD in Combination with Ponatinib for Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Koji Sasaki, MD, Elias J. Jabbour, MD, Farhad Ravandi, MD, Naval G. Daver, MD, Naveen Pemmaraju, MD, Deborah A Thomas, MD, Rita B. Khouri, Musa Yilmaz, MD, Tapan M. Kadia, MD, Nicholas J. Short, MD, Rebecca Garris, MS, Guillermo Garcia-Manero, MD, Courtney D DiNardo, MD, Marina Konopleva, MD PhD, Zeev Estrov, MD, Nitin Jain, MD, William G. Wierda, MD PhD, Twilla Victoria Jeanis, RN, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2016) 128 (22): 757.
https://doi.org/10.1182/blood.V128.22.757.757
Published: 2016
Journal Articles

Patterns of Relapse in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Who Achieve Complete Molecular Response with Chemotherapy Plus a Tyrosine Kinase Inhibitor

Nicholas J. Short, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Rebecca Garris, MS, Susan M. O'Brien, MD, Keyur P. Patel, MD PhD, Jeffrey L. Jorgensen, MD PhD, Joseph D Khoury, MD, Guillermo Garcia-Manero, MD, Deborah A Thomas, MD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2016) 128 (22): 3977.
https://doi.org/10.1182/blood.V128.22.3977.3977
Published: 2016
Journal Articles

Phase II Study of the Salvage Mini-Hyper-CVD in Combination with Inotuzumab Ozogamicin (INO) for Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Koji Sasaki, MD, Elias J. Jabbour, MD, Susan M. O'Brien, MD, Farhad Ravandi, MD, Deborah A Thomas, MD, Tapan M. Kadia, MD, Guillermo Garcia-Manero, MD, Jan A. Burger, MD PhD, Naveen Pemmaraju, MD, Yesid Alvarado, MD, Naval G. Daver, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Richard E. Champlin, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, David Marin, MD, Courtney D DiNardo, MD, Zeev Estrov, MD, Koichi Takahashi, MD, Nicholas J. Short, MD, Maria R. Khouri, Jovitta Jacob, RN, Rebecca Garris, MS, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2016) 128 (22): 1606.
https://doi.org/10.1182/blood.V128.22.1606.1606
Published: 2016
Journal Articles

Additional Chromosomal Abnormalities in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Tyrosine Kinase Inhibitors: Differential Outcomes According to Type of Chromosomal Abnormality

Nicholas J. Short, MD, Elias J. Jabbour, MD, Koji Sasaki, MD, Heidi Ko, MD, Farhad Ravandi, MD, C. Cameron Yin, MD PhD, Maria R. Khouri, Jorge E. Cortes, MD, Rebecca Garris, MS, Susan M. O'Brien, MD, Keyur P. Patel, MD PhD, Guillermo Garcia-Manero, MD, Deborah A Thomas, MD, Naval Daver, MD, Kiran Naqvi, MD, Prithviraj Bose, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2016) 128 (22): 1737.
https://doi.org/10.1182/blood.V128.22.1737.1737
Published: 2016
Journal Articles

Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) As Frontline Therapy for Older Patients with Acute Lymphoblastic Leukemia (ALL): Interim Result of a Phase II Clinical Trial

Koji Sasaki, MD, Elias J. Jabbour, MD, Susan M. O'Brien, MD, Farhad Ravandi, MD, Deborah A Thomas, MD, Guillermo Garcia-Manero, MD, Naval Daver, MD, Gautam Borthakur, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Nicholas J. Short, MD, Naveen Pemmaraju, MD, Yesid Alvarado, MD, Jovitta Jacob, RN, Rebecca Garris, MS, Philip A Thompson, MBBS, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2016) 128 (22): 588.
https://doi.org/10.1182/blood.V128.22.588.588
Published: 2016
Journal Articles

Methotrexate Clearance in Adult Patients with B-Precursor Acute Lymphoblastic Leukemia Treated with the Mini-Hyper-CVD Regimen

Yogin B Patel, PharmD, Kelsey N Voit, PA, Koji Sasaki, MD, Farhad Ravandi, MD, Deborah A Thomas, MD, Susan M. O'Brien, MD, Gautam Borthakur, MBBS, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Marina Konopleva, MD PhD, Nitin Jain, MD, Maro Ohanian, DO, Rebecca Garris, MS, Jovitta Jacob, RN, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2016) 128 (22): 5194.
https://doi.org/10.1182/blood.V128.22.5194.5194
Published: 2016
Journal Articles

Clinical Implications of TP53 Mutations in Adult Patients with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) Treated with the Hypercvad-Based Regimens

Rashmi Kanagal-Shamanna, MD, Preetesh Jain, MBBS, MDDM, PhD, Raja Luthra, PhD, Keyur P. Patel, MD PhD, Guillermo Garcia-Manero, MD, Koichi Takahashi, MD, Farhad Ravandi, MD, Koji Sasaki, MD, Tapan M. Kadia, MD, Gautam Borthakur, MD, Marina Konopleva, MD PhD, Nitin Jain, MD, Rebecca Garris, MS, Sherry Pierce, BSN, BA, Zeev Estrov, MD, William G. Wierda, MD PhD, Susan M. O'Brien, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2016) 128 (22): 2917.
https://doi.org/10.1182/blood.V128.22.2917.2917
Published: 2016